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he clinical characters of acute ﬂaccid paralysis associated with
nterovirus 71 infected hand-foot-mouth disease
. Yingxue, F. Hongna ∗, G. Yongsheng, W. Bo
Tianjin Children’s Hospital,China, Tianjin, China
Background: Hand-foot-mouth disease (HFMD) outbreaks in
oung children in recent years. A signiﬁcant increase in the num-
er of HFMD cases in China over the last 4y has made the public
revention and therapy of this disease a critical issue. Enterovirus
1 (EV71) was the major causative agent of the HFMD outbreak
nTianjin.Our objective is to analyze the clinical characteristics of
cute ﬂaccid paralysis (AFP) caused by EV71 HFMD.
Methods: 10 cases HFMD (6 male, 4 female) complicated with
FP were enrolled. The clinical manifestations were observed
eanwhile the etiological results, spinal cord MRI ﬁndings, clinical
lectroneurophysiology ﬁndings cerebrospinal ﬂuid were col-
ected. The recoveries of their impairment in limb extremitieswere
ollowed up for 2 or 3 months.
Results:AFP associatedwith enterovirus 71 infected HFMDwas
articularly prevalent in children less than 2 years old, all of whom
ad skin rash and fever. 70% of the cases had acute paralysis with
ingle limb. Muscle power was initially improved in a week. All
ases got obvious recovery in hospital and mild paralysis could
ecover in 1 or 3 months. Findings of MRI and electroneurophysi-
logy were in highly accordance with clinical symptoms, both can
rovide the basis of focal neurological signs. Being followedup for 2
r 3months, all children′smyodynamia of paralysis limbs gradually
ecovered, 7 cases (70%) return to V grade.
Conclusion: CNS involvement is the serious complication
aused by EV71 infection and EV71 may be the great virus of non-
olio enterovirus (NPEV). MRI and electroneurophysiology have
mportant value to evaluate patients′ condition and prognosis. In
cute stage, mortality and disability rate can be reduced effectively
y all-around and actively intreatment. It is effective in clinical
bservation by combined treatmentwith intravenous immue glob-
lin (IVIG) and glucocorticoid.
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Clinical effectiveness of three-combination probiotics therapy
in pediatric patients with salmonella and rotavirus gastroen-
teritis: randomised clinical trial
Y.F. Huang ∗, P.-Y. Liu, K.-S. Hsieh
Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C
Background: Including our previous report, several studies
show that rotavirus infection and salmonella infection are the lead-
ing causes of infectious gastroenteritis. Quantitative Vesikari scales
and qualitative severe diarrhea (Vesikari scale≥11) approaches
were used to grade the severity of salmonella and rotavirus gas-
troenteritis and post-hospital days were used to evaluate the
efﬁcacy of three-combination probiotics (BIO-THREE®).
Methods: A single-center, open-label, randomized, controlled
trial was conducted to collect 159 patients aged 3 months to
14 years and hospitalized with infectious gastroenteritis between
February 2009 and October 2010. After written informed consent
was obtained, subjects were randomized to receive conventional
treatmentor add-on treatmentof theprobiotics to the conventional
treatment.
Results: 159 patients were enrolled in the study. According to
the treatment, 82childrenwere randomized to the treatmentgroup
and 77 children to the control group; according to the pathogen
identiﬁed, 48 patients were then grouped into the Salmonella
group, 42 to the Rotavirus group and 69 to other AGE group. Total
duration of diarrhea was signiﬁcantly shorter for children receiv-
ing Bio-three® (p< 0.0001). After Bio-three® was offered, all the
patients in the treatment group demonstrated signiﬁcant improve-
ment at day 5 and 7 (p<0.05, respectively), patients with severe
diarrhea (vesikari scale≥11) inall threepathogensub-groupsbegan
to show signiﬁcant improvement fromday 3 (p<0.01), the Vesikari
scale of patients in the Rotavirus group was signiﬁcantly improved
at day 5 (P =0.04), and no severe diarrhea was found in the
salmonella group at day 5 and 7 (p=0.49).
Conclusion: In conclusion, seven days of Bio-three® demon-
stratedhighefﬁcacyand safety to infants andchildrenpatientswith
severe gastroenteritis and the incidence of severe gastroenteritis
was signiﬁcantly reduced in the rotavirus-originated group.
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